• Methylpredni Sodium Succinate for Injection 125mg 40mg
  • Methylpredni Sodium Succinate for Injection 125mg 40mg
  • Methylpredni Sodium Succinate for Injection 125mg 40mg
  • Methylpredni Sodium Succinate for Injection 125mg 40mg

Methylpredni Sodium Succinate for Injection 125mg 40mg

Application: Internal Medicine
Usage Mode: Im/IV
Suitable for: Elderly, Children, Adult
State: Lyophilization
Shape: Powder
Type: Organic Chemicals
Samples:
US$ 1/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Gold Member Since 2017

Suppliers with verified business licenses

Trading Company

Basic Info.

Model NO.
40mg125mg
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
Guoyaozhuizhih20203238
Transport Package
Box
Specification
40mg 125mg
Origin
Chong Qing
HS Code
3004909099
Production Capacity
50000000vials

Product Description

Methylpredni sol one Sodium Succinate
for Injection


DrugGenericName:Methyprednisolone
sodiumsuccinateforInjection
strength :40mg  125mg
DosageForm: injection


Indications Thisproductissuitableforthereplacementtreatmentofsomeendocrinedisorders.Glucocorticoidisonlyasymptomatictreatment.
1,Anti-infammatorytreatmentrheumaticdiseases:usedasadjuvantmedicineforshort-termuse(tohelppatientsthroughtheacuteorcritical
period),for:post-traumaticosteoarthritis;synovitiscausedbyosteoarthritis;Rheumatoidarthritis,includingjuvenilerheumatoidarthritis(individual
patientsmayreqirelow-dosemaintenancetherapy):Acuteorsubacutebursitis;ontheankleinflammation;Acutenon-specifcjiansheaths
inammation;Acutegoutarthritis;psoriaticarthritis;Ankylosingspondylitis.
2,collagendiseses(diseasesofimmunecomplex):forcriticalormaintenancetreatmentofthefollowingdiseases:systemiclupuserythematosus
(andlupusnephritis);Acuterheumaticmyocarditis;systemicdermatomyositis(polymyositis):Nodularpolyarteritis;Goodllpasstorusyndrome
(Goodpasture'ssyndrome).
3,skindiseases:pemphigus;severeerythemapolymorpha(stevensJohsonsyndrome);Exfoliativedermatitis;Dermatitisvesicular;seborrheic
dermatitis;severepsoriasis;Mycosisfungoidesurticaria.
4,Allergicstatus:forthecontrolofsevereordisablingallergicdiseasesthatarediffculttotreatwithconventionaltherapyBronchial
asthma;contactdermatits;Heterotopicdermatitis;serumsickess;seasonaloryear-roundallergicrhinitis;Alergicreactionstodrugs;urticaria-like
transfusionreaction;Acutenon-infectiouslaryngealedema(epinephrineispreferred).
5,Eyediseases:severeacuteandchroniceyeirritationandinfammation,suchasherpeszosterIritis,iridocyclitis;choroidalretinitis;Diffuse

 
 

Methylpredni sol one Sodium Succinate
for Injection

7,Respiratorydiseses:pulmonarysarcoma;Berylliumpoisoninguseincombinationwithappropriateanti-tuberculosischemotherapyforfulflsordiffuse

9,Immunosuppressivetherapy:
(1organtransplantation:tretmentofblooddisesesandtumors.
(2)Blooddiseases:acquired(autoimmune)hemolyticanemia;spontaeousthrombocytopenicpurpurainadults(intravenousonlycontraindicated
intramuscular):secondarythrombocytopenianadults;Erythropoiesis(erythrocyticanemia):congenitalanaemiaduetopoorregenerationofredbloodcels.
(3)Tumor:forpalliativecareofthefollowingdiseses;Adultleukemiaandlymphoma;Acuteleukemiainchildren.
10,Treatmentforshock:shocksecondarytoadrenocorticaldysfunction,orshockthatdoesnotrespondtoconventionltreatmetdetopossible
adrenocorticaldysfunction(hydrocortisoneiscommonlyused;Methylprednisolonemybeusedifsaltcorticosteroidactvityisnotdesired.Hemorrhagic,
traumatic,andsurgicalshockthatdoesnotrespondtoconventionaltreatmet.Althoughtherearenowell-developed(double-blindcontrolled)clinical
studies,dtafromanimalstudiessuggestthatthisproductmaybeefectiveforshockinpatientswhodonotrespondtoconventionaltreatmentsuchas
uidreplacement.
pleasealsorefertothe"septicshock"sectionofnotes.
11,other:
(1Nervoussystem:cerebraledemacausedbyprimaryormetastatictumors,and/orsurgeryandradiotherapyAcutecriticalstageofmutiple
sclerosis;AcutespinalcordinjuryTreatmentshouldbeginwithin8hoursoftrauma.
(2)usedinconjnctionwithappropriateatituberculouschemotherapyfortuberculousmeningitiswithortendingtoobstructionofthesubarachnoid
space.
(3)Tichinosisinvolvingthenervesormyocardium.
(4)preventnauseaandvomitingcausedbycancerchemotherapy.
12,Endocrinedisorders:primaryorsecondaryadrenalcorticaldysfunctonAcuteadrenlcorticaldysfunction;(hydrocortisoneorcortisoneispreferredfor
theabovediseases.Ifnecessarysyntheticglucocorticoidsmaybecombinedwithcorticosteroids.)patietswhoareknowntohaveormayhave
adrenocorticaldysfunctionaregivenpreoperativelyandintheeventofseveretraumaorillness.congenitaladrenalhyperplasia;Nonsuppurative
 

Methylpredni sol one Sodium Succinate
for Injection

Product physical picture:
40mg

 
 

Methylpredni sol one Sodium Succinate
for Injection
Product physical picture:
125mg


 


Methylpredni sol one Sodium Succinate
for Injection

External box physical picture:


 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

People who viewed this also viewed

Find Similar Products By Category

Supplier Homepage Products Pharmaceuticals Methylpredni Sodium Succinate for Injection 125mg 40mg

You Might Also Like

Gold Member Since 2017

Suppliers with verified business licenses

Trading Company
Management System Certification
ISO 9001, ISO 9000, GMP, HACCP, BREEAM
Export Year
2016-07-01